Delivery Order SPE2D021DA002-SPE2D325F308G
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $20,936.20 for 60 tablets of Isentress 400 mg on September 29, 2025. The contract, which has no set-aside designation, is set to conclude on September 30, 2025, and will be performed at the vendor's Park Ridge, Illinois location. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18.8K on August 25, 2025, for the supply of Isentress 400 mg tablets (60-count units). The award was issued by the Defense Logistics Agency's Medical Supply Chain division with an ultimate completion date of August 26, 2025. This delivery order carries no set-aside designation and represents a single purchase order under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $2,093.62 for the supply of Isentress 400 mg tablets (60-count) to the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a tactical procurement of antiretroviral medication to support Department of Defense...
- The U.S. Defense Logistics Agency, operating through the Medical Supply Chain division, awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for $2,093.62 on September 29, 2025. The order covers 60 tablets of Isentress 400 mg, an antiretroviral medication used in HIV treatment, with delivery to Park Ridge, Illinois and a completion deadline of September 30, 2025. This delivery order was issued without a set-aside designation, leveraging the vendor's status as a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Isentress 400 mg tablets. The contract, valued at $1,381.17, has an ultimate completion date of April 30, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,381.17, is for the delivery of Isentress 400 mg tablets. This order is part of a larger indefinite delivery contract, SPE2DB, that DMS Pharmaceutical Group holds with DLA, valued up to $4,999,999 through 2025. Through this IDV, DMS Pharmaceutical provides a wide...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,381.17 firm fixed-price contract is for the supply of ISENTRESS 400 MG tablets, and has a completion date of June 3, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
- This federal contract award, valued at $13,811.70, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Isentress 400 mg tablets, with a completion date of June 25, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- This delivery order, valued at $1,429.30, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Isentress 400 mg tablets (60-count units). The award was issued on June 6, 2025, under a firm fixed-price contract type with an ultimate completion date of June 11, 2025. The product will be delivered to Park Ridge, Illinois, and the contract was funded by the Defense Logistics Agency's Medical Supply Chain...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $16,574.04 firm-fixed-price contract is for the delivery of Isentress 400 mg tablets, a prescription pharmaceutical product. The contract has a completion date of January 29, 2024. DMS Pharmaceutical Group Inc. holds an indefinite delivery contract, SPE2DB, with the DLA valued up to $4,999,999...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F308GDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 11, 2025, for the supply of Isentress 400 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $2,093.62. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499.99 million and valid through November 2026. The contract carries no set-aside designation, and the place of performance is Park Ridge, Illinois, with an ultimate completion date of August 12, 2025. The funding source is the Medical Supply Chain, a defense-oriented federal agency. Isentress is an antiretroviral medication used in the treatment of human immunodeficiency virus (HIV) infection. This delivery order reflects DMS Pharmaceutical Group's role as a critical supplier within the federal pharmaceutical supply chain, providing prescription medications and medical consumables to Department of Defense healthcare facilities nationwide. The company's comprehensive contract portfolio with the DLA demonstrates its consistent capacity to deliver specialty pharmaceuticals, including antiretroviral drugs, oncology treatments, biologics, and other essential medications supporting military health operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/11/25 |